High Insulin Levels in KK-Ay Diabetic Mice Cause Increased Cortical Bone Mass and Impaired Trabecular Micro-structure

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2015 Apr 15

PMID 25872143

Citations 13

Authors

Cen Fu

Xiaolin Zhang

Fei Ye

Jianhong Yang

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by hyperglycemia, hyperinsulinemia and complications, including obesity and osteoporosis. Rodents have been widely used to model human T2DM and investigate its effect on the skeleton. We aimed to investigate skeletal alterations in Yellow Kuo Kondo (KK-Ay) diabetic mice displaying high insulin and glucose levels. Bone mineral density (BMD), micro-architecture and bone metabolism-related genes were analyzed. The total femoral areal BMD (aBMD), cortical volumetric BMD (vBMD) and thickness were significantly increased in KK-Ay mice, while the trabecular vBMD and mineralized bone volume/tissue volume (BV/TV), trabecular thickness and number were decreased compared to C57BL mice. The expression of both osteoblast-related genes, such as osteocalcin (OC), bone sialoprotein, Type I Collagen, osteonectin, RUNX2 and OSX, and osteoclast-related genes, such as TRAP and TCIRG, were up-regulated in KK-Ay mice. Correlation analyses showed that serum insulin levels were positively associated with aBMD, cortical vBMD and thickness and negatively associated with trabecular vBMD and micro-architecture. In addition, serum insulin levels were positively related to osteoblast-related and osteoclast-related gene expression. Our data suggest that high insulin levels in KK-Ay diabetic mice may increase cortical bone mass and impair trabecular micro-structure by up-regulating osteoblast-and osteoclast-related gene expression.

Citing Articles

Role of oxidative stress in impaired type II diabetic bone repair: scope for antioxidant therapy intervention?.

Li P, Alenazi K, Dally J, Woods E, Waddington R, Moseley R Front Dent Med. 2025; 5:1464009.

PMID: 39917650 PMC: 11797775. DOI: 10.3389/fdmed.2024.1464009.

Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs.

Janapati Y, Junapudi S Animal Model Exp Med. 2024; 7(3):297-309.

PMID: 38837635 PMC: 11228097. DOI: 10.1002/ame2.12442.

Metabolic and Skeletal Characterization of the KK/A Mouse Model-A Polygenic Mutation Model of Obese Type 2 Diabetes.

Chowdhury N, Surowiec R, Kohler R, Reul O, Segvich D, Wallace J Calcif Tissue Int. 2024; 114(6):638-649.

PMID: 38642089 PMC: 11184323. DOI: 10.1007/s00223-024-01216-1.

Insights and implications of sexual dimorphism in osteoporosis.

Zhang Y, Xie N, Sun X, Nice E, Liou Y, Huang C Bone Res. 2024; 12(1):8.

PMID: 38368422 PMC: 10874461. DOI: 10.1038/s41413-023-00306-4.

Energy Metabolism and Ketogenic Diets: What about the Skeletal Health? A Narrative Review and a Prospective Vision for Planning Clinical Trials on this Issue.

Merlotti D, Cosso R, Eller-Vainicher C, Vescini F, Chiodini I, Gennari L Int J Mol Sci. 2021; 22(1).

PMID: 33406758 PMC: 7796307. DOI: 10.3390/ijms22010435.

References

Bhattoa H, Onyeka U, Kalina E, Balogh A, Paragh G, Antal-Szalmas P . Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study. Clin Rheumatol. 2013; 32(8):1161-7. DOI: 10.1007/s10067-013-2254-y. View

Zhang Y, Yang J . Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts. J Cell Biochem. 2013; 114(11):2595-602. DOI: 10.1002/jcb.24607. View

Freude T, Braun K, Haug A, Pscherer S, Stockle U, Nussler A . Hyperinsulinemia reduces osteoblast activity in vitro via upregulation of TGF-β. J Mol Med (Berl). 2012; 90(11):1257-66. DOI: 10.1007/s00109-012-0948-2. View

Shu A, Yin M, Stein E, Cremers S, Dworakowski E, Ives R . Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int. 2011; 23(2):635-41. PMC: 3690650. DOI: 10.1007/s00198-011-1595-0. View

Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865):813-20. DOI: 10.1038/414813a. View

Emrich L, Shlossman M, Genco R . Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol. 1991; 62(2):123-31. DOI: 10.1902/jop.1991.62.2.123. View

Sosa M, Dominguez M, Navarro M, Segarra M, Hernandez D, De Pablos P . Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complications. 1996; 10(4):201-5. DOI: 10.1016/1056-8727(95)00062-3. View

Takagi S, Miura T, Yamashita T, Ando N, Nakao H, Ishihara E . Characteristics of diabetic osteopenia in KK-Ay diabetic mice. Biol Pharm Bull. 2012; 35(3):438-43. DOI: 10.1248/bpb.35.438. View

Kook S, Heo J, Lee J . Crucial roles of canonical Runx2-dependent pathway on Wnt1-induced osteoblastic differentiation of human periodontal ligament fibroblasts. Mol Cell Biochem. 2015; 402(1-2):213-23. DOI: 10.1007/s11010-015-2329-y. View

10.

Manolagas S . Wnt signaling and osteoporosis. Maturitas. 2014; 78(3):233-7. PMC: 4065196. DOI: 10.1016/j.maturitas.2014.04.013. View

11.

Fajardo R, Karim L, Calley V, Bouxsein M . A review of rodent models of type 2 diabetic skeletal fragility. J Bone Miner Res. 2014; 29(5):1025-40. PMC: 5315418. DOI: 10.1002/jbmr.2210. View

12.

Pritchard J, Giangregorio L, Atkinson S, Beattie K, Inglis D, Ioannidis G . Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls. Arthritis Care Res (Hoboken). 2012; 64(1):83-91. PMC: 5096917. DOI: 10.1002/acr.20602. View

13.

Petit M, Paudel M, Taylor B, Hughes J, Strotmeyer E, Schwartz A . Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res. 2009; 25(2):285-91. PMC: 3153385. DOI: 10.1359/jbmr.090725. View

14.

Malvi P, Piprode V, Chaube B, Pote S, Mittal M, Chattopadhyay N . High fat diet promotes achievement of peak bone mass in young rats. Biochem Biophys Res Commun. 2014; 455(1-2):133-8. DOI: 10.1016/j.bbrc.2014.10.131. View

15.

Hamann C, Kirschner S, Gunther K, Hofbauer L . Bone, sweet bone--osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol. 2012; 8(5):297-305. DOI: 10.1038/nrendo.2011.233. View

16.

Burghardt A, Issever A, Schwartz A, Davis K, Masharani U, Majumdar S . High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010; 95(11):5045-55. PMC: 2968722. DOI: 10.1210/jc.2010-0226. View

17.

Nordentoft I, Jeppesen P, Hong J, Abudula R, Hermansen K . Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-mice after feeding with a soy bean protein rich diet high in isoflavone content. J Agric Food Chem. 2008; 56(12):4377-85. DOI: 10.1021/jf800504r. View

18.

Patsch J, Kiefer F, Varga P, Pail P, Rauner M, Stupphann D . Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metabolism. 2010; 60(2):243-9. PMC: 6342255. DOI: 10.1016/j.metabol.2009.11.023. View

19.

Oei L, Zillikens M, Dehghan A, Buitendijk G, Castano-Betancourt M, Estrada K . High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care. 2013; 36(6):1619-28. PMC: 3661786. DOI: 10.2337/dc12-1188. View

20.

Melton 3rd L, Riggs B, Leibson C, Achenbach S, Camp J, Bouxsein M . A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab. 2008; 93(12):4804-9. PMC: 2626440. DOI: 10.1210/jc.2008-0639. View